William Pickering
Stock Analyst at Argus Research
(1.70)
# 3,338
Out of 5,182 analysts
36
Total ratings
45.45%
Success rate
-2.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics | Maintains: Market Perform | $1.6 → $3.85 | $2.31 | +66.67% | 3 | Apr 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $925 → $921 | $751.57 | +22.54% | 4 | Apr 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $90 → $94 | $53.18 | +76.76% | 6 | Feb 25, 2026 | |
| BEAM Beam Therapeutics | Maintains: Outperform | $37 → $41 | $27.11 | +51.24% | 2 | Jan 21, 2026 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Outperform | n/a | $430.29 | - | 6 | Jan 12, 2026 | |
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $73.28 | +28.28% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $9.88 | -8.91% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $184.38 | -14.85% | 1 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $13.63 | +6.38% | 2 | Oct 28, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $20.30 | -35.96% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $314 → $310 | $305.54 | +1.46% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $27 → $24 | $73.91 | -67.53% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $73.27 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $48.79 | -9.81% | 1 | Mar 21, 2023 |
Allogene Therapeutics
Apr 14, 2026
Maintains: Market Perform
Price Target: $1.6 → $3.85
Current: $2.31
Upside: +66.67%
Regeneron Pharmaceuticals
Apr 8, 2026
Maintains: Outperform
Price Target: $925 → $921
Current: $751.57
Upside: +22.54%
BioMarin Pharmaceutical
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $94
Current: $53.18
Upside: +76.76%
Beam Therapeutics
Jan 21, 2026
Maintains: Outperform
Price Target: $37 → $41
Current: $27.11
Upside: +51.24%
Vertex Pharmaceuticals
Jan 12, 2026
Upgrades: Outperform
Price Target: n/a
Current: $430.29
Upside: -
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $73.28
Upside: +28.28%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $9.88
Upside: -8.91%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $184.38
Upside: -14.85%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $13.63
Upside: +6.38%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $20.30
Upside: -35.96%
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $305.54
Upside: +1.46%
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $73.91
Upside: -67.53%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $73.27
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $48.79
Upside: -9.81%